4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-055732
Chief Executive Officer sold 100,000 shares at an average $58.21 ($5,821,032)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2020-10-23 | Sale | −87,728 | $58.16 | $5,102,260 | 2,517,509 | D: show line 1 in the form |
| Anzalone Christopher Richard Chief Executive Officer | 2020-10-23 | Sale | −12,272 | $58.57 | $718,771 | 2,505,237 | D: show line 2 in the form |
| Open-market sales · 100,000 sh · avg $58.21 · $5,821,032 | |||||||
Loading xslF345X03/doc4.xml…